Literature DB >> 20532641

Antioxidant, antinociceptive and anti-inflammatory activities of atorvastatin and rosuvastatin in various experimental models.

Mahesh M Ghaisas1, Prasad R Dandawate, Suyash A Zawar, Yogesh S Ahire, Santosh P Gandhi.   

Abstract

The present study was planned to investigate the antioxidant, antinociceptive, and anti-inflammatory activities of atorvastatin and rosuvastatin (1, 3 and 10 mg/kg, p.o.) in various animal models. The antinociceptive effect was assessed by chemically- (formalin, acetic acid) and thermally- (hot plate) induced nociception, while anti-inflammatory effect was evaluated using carrageenan-, formaldehyde-induced paw oedema and cotton pellet-induced granuloma. The effect of atorvastatin and rosuvastatin on liver antioxidant enzymes like superoxide dismutase, glutathione, LPO, CAT along with the effect on lactate dehydrogenase (LDH) and alkaline phosphatase (ALP) was evaluated in the cotton pellet-induced granuloma model. Atorvastatin and rosuvastatin showed significant decrease (p < 0.05) in carrageenan- and formaldehyde-induced rat paw oedema and reduced granuloma formation in the cotton pellet-induced granuloma method (p < 0.01) while the levels of LDH and ALP were also significantly decreased (p < 0.05). The liver antioxidant enzyme levels were found to be restored (p < 0.05). Atorvastatin and rosuvastatin also showed antinociceptive activities (p < 0.05 and p < 0.01) in the acetic acid- and formalin-induced nociception in mice, while there was no significant activity in the hot plate method. The present findings suggest that atorvastatin and rosuvastatin possess dose-dependent antioxidant, analgesic, and anti-inflammatory activities.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20532641     DOI: 10.1007/s10787-010-0044-6

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  46 in total

1.  Cardiovascular disease. Does inflammation cut to the heart of the matter?

Authors:  Gary Taubes
Journal:  Science       Date:  2002-04-12       Impact factor: 47.728

2.  Statins promote potent systemic antioxidant effects through specific inflammatory pathways.

Authors:  Mehdi H Shishehbor; Marie-Luise Brennan; Ronnier J Aviles; Xiaoming Fu; Marc S Penn; Dennis L Sprecher; Stanley L Hazen
Journal:  Circulation       Date:  2003-07-14       Impact factor: 29.690

3.  Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat.

Authors:  L R Watkins; D Martin; P Ulrich; K J Tracey; S F Maier
Journal:  Pain       Date:  1997-07       Impact factor: 6.961

4.  The formalin test in mice: dissociation between inflammatory and non-inflammatory pain.

Authors:  Steinar Hunskaar; Kjell Hole
Journal:  Pain       Date:  1987-07       Impact factor: 6.961

5.  Modulation of formalin-induced behaviors and edema by local and systemic administration of dextromethorphan, memantine and ketamine.

Authors:  Jana Sawynok; Allison Reid
Journal:  Eur J Pharmacol       Date:  2002-08-23       Impact factor: 4.432

6.  Production of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 alpha by inflammatory granuloma fibroblasts.

Authors:  N W Lukacs; S W Chensue; R E Smith; R M Strieter; K Warmington; C Wilke; S L Kunkel
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

7.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Authors:  J R Downs; M Clearfield; S Weis; E Whitney; D R Shapiro; P A Beere; A Langendorfer; E A Stein; W Kruyer; A M Gotto
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272

8.  Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus.

Authors:  Alexander Riad; Jing Du; Sebastian Stiehl; Dirk Westermann; Zarah Mohr; Meike Sobirey; Wolfram Doehner; Volker Adams; Matthias Pauschinger; Heinz Peter Schultheiss; Carsten Tschöpe
Journal:  Eur J Pharmacol       Date:  2007-05-24       Impact factor: 4.432

9.  Studies on the antinociceptive action of alpha-agonist drugs and their interactions with opioid mechanisms.

Authors:  G A Bentley; S H Newton; J Starr
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

10.  In-vivo effects of simvastatin and rosuvastatin on global gene expression in peripheral blood leucocytes in a human inflammation model.

Authors:  Wolfgang M Schmidt; Alexander O Spiel; Bernd Jilma; Michael Wolzt; Markus Müller
Journal:  Pharmacogenet Genomics       Date:  2008-02       Impact factor: 2.089

View more
  19 in total

1.  Effect of simvastatin on sensorial, motor, and morphological parameters in sciatic nerve crush induced-neuropathic pain in rats.

Authors:  Claudia Rita Corso; Daniel Fernandes Martins; Stephanie Carvalho Borges; Olair Carlos Beltrame; José Ederaldo Queiroz Telles; Nilza Cristina Buttow; Maria Fernanda de Paula Werner
Journal:  Inflammopharmacology       Date:  2017-11-29       Impact factor: 4.473

2.  Effects of Topical Atorvastatin (2 %) on Posthemorrhoidectomy Pain and Wound Healing: A Randomized Double-Blind Placebo-Controlled Clinical Trial.

Authors:  Shahram Ala; Mina Alvandipour; Majid Saeedi; Maliheh Hamidian; Afshin Shiva; Nasrin Rahmani; Fatemeh Faramarzi
Journal:  World J Surg       Date:  2017-02       Impact factor: 3.352

3.  Low-dose atorvastatin, losartan, and particularly their combination, provide cardiovascular protection in isolated rat heart and aorta.

Authors:  Mojca Lunder; Lovro Ziberna; Miodrag Janić; Aleš Jerin; Milan Skitek; Mišo Sabovič; Gorazd Drevenšek
Journal:  Heart Vessels       Date:  2012-05-21       Impact factor: 2.037

4.  Rosuvastatin Attenuates High-Salt and Cholesterol Diet Induced Neuroinflammation and Cognitive Impairment via Preventing Nuclear Factor KappaB Pathway.

Authors:  Ibraheem Husain; Mohd Akhtar; Divya Vohora; Malik Zainul Abdin; Mohammad Islamuddin; Mohd Jawaid Akhtar; Abul Kalam Najmi
Journal:  Neurochem Res       Date:  2017-04-18       Impact factor: 3.996

5.  Atorvastatin exhibits anti-inflammatory and anti-oxidant properties in adjuvant-induced monoarthritis.

Authors:  V L Kumar; B Guruprasad; V D Wahane
Journal:  Inflammopharmacology       Date:  2010-10-31       Impact factor: 4.473

6.  An experimental study of rosuvastatin's analgesic effect and its interaction with etoricoxib, tramadol, amlodipine, and amitriptytline in albino mice.

Authors:  Prafull Mohan; Ashok Kumar Sharma; Sharmila Sinha; R Sabarad
Journal:  Med J Armed Forces India       Date:  2021-08-27

7.  Effects of simvastatin, ezetimibe, and their combination on histopathologic alterations caused by adjuvant-induced arthritis.

Authors:  Carmem Patrícia Barbosa; Alessandra Milene Ritter; Lorena Gimenez da Silva; Renata Grespan; Roberto Kenji Nakamura Cuman; Luzmarina Hernandes; Ciomar Aparecida Bersani-Amado
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

8.  High-salt- and cholesterol diet-associated cognitive impairment attenuated by tannins-enriched fraction of Emblica officinalis via inhibiting NF-kB pathway.

Authors:  Ibraheem Husain; Mohd Akhtar; Mohammad Shaharyar; Mohammad Islamuddin; Malik Zainul Abdin; Mohd Jawaid Akhtar; Abul Kalam Najmi
Journal:  Inflammopharmacology       Date:  2018-01-15       Impact factor: 4.473

9.  Antinociceptive effects of radon inhalation on formalin-induced inflammatory pain in mice.

Authors:  Keiko Yamato; Takahiro Kataoka; Yuichi Nishiyama; Takehito Taguchi; Kiyonori Yamaoka
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

10.  Amaranthus spinosus Attenuated Obesity-Induced Metabolic Disorders in High-Carbohydrate-High-Fat Diet-Fed Obese Rats.

Authors:  Md Raihan Uzzaman Prince; S M Neamul Kabir Zihad; Puja Ghosh; Nazifa Sifat; Razina Rouf; Gazi Mohammad Al Shajib; Md Ashraful Alam; Jamil A Shilpi; Shaikh J Uddin
Journal:  Front Nutr       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.